BPJTZVJFAKRZMN-HNNXBMFYSA-N
C25H26ClF4N3O7S — CID 118181113
Data last refreshed: (MolForge compound catalog, from PubChem)
About BPJTZVJFAKRZMN-HNNXBMFYSA-N
BPJTZVJFAKRZMN-HNNXBMFYSA-N (PubChem CID 118181113) has the molecular formula C25H26ClF4N3O7S and a molecular weight of 624.01 g/mol. Its IUPAC name is (1,1,1-trifluoro-2-methylpropan-2-yl) N-[(2S)-4-(3-chloro-4-fluorophenyl)sulfonyl-2-[[(1-hydroxycyclobutanecarbonyl)amino]methyl]-2,3-dihydro-1,4-benzoxazin-6-yl]carbamate.
Molecular Properties
| Compound Name | BPJTZVJFAKRZMN-HNNXBMFYSA-N |
|---|---|
| PubChem CID | 118181113 |
| Molecular Formula | C25H26ClF4N3O7S |
| Molecular Weight | 624.01 g/mol |
| Exact Mass | 623.11 |
| IUPAC Name | (1,1,1-trifluoro-2-methylpropan-2-yl) N-[(2S)-4-(3-chloro-4-fluorophenyl)sulfonyl-2-[[(1-hydroxycyclobutanecarbonyl)amino]methyl]-2,3-dihydro-1,4-benzoxazin-6-yl]carbamate |
| SMILES | CC(C)(OC(=O)Nc1ccc2c(c1)N(S(=O)(=O)c1ccc(F)c(Cl)c1)C[C@H](CNC(=O)C1(O)CCC1)O2)C(F)(F)F |
| InChI | InChI=1S/C25H26ClF4N3O7S/c1-23(2,25(28,29)30)40-22(35)32-14-4-7-20-19(10-14)33(41(37,38)16-5-6-18(27)17(26)11-16)13-15(39-20)12-31-21(34)24(36)8-3-9-24/h4-7,10-11,15,36H,3,8-9,12-13H2,1-2H3,(H,31,34)(H,32,35)/t15-/m0/s1 |
| InChIKey | BPJTZVJFAKRZMN-HNNXBMFYSA-N |
| XLogP | 4.36 |
| TPSA | 134.27 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 624.01 |
| LogP ≤ 5 | 4.36 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118181113 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.